Published in J Chromatogr A on December 26, 2011
Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. Anal Chem (2012) 1.26
Oligosaccharide analysis by mass spectrometry: a review of recent developments. Anal Chem (2013) 1.10
The circulating glycosaminoglycan signature of respiratory failure in critically ill adults. J Biol Chem (2014) 1.00
Cell-Based Microscale Isolation of Glycoaminoglycans for Glycomics Study. J Carbohydr Chem (2012) 0.93
Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection. Nat Protoc (2014) 0.92
Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection. Anal Biochem (2012) 0.90
An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides. Anal Chem (2013) 0.87
De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides. Anal Chem (2016) 0.85
Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site. J Biol Chem (2013) 0.83
Combinatorial one-pot chemoenzymatic synthesis of heparin. Carbohydr Polym (2014) 0.81
Carbohydrate-containing molecules as potential biomarkers in colon cancer. OMICS (2014) 0.81
Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin. Glycoconj J (2013) 0.81
Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing. J Biol Chem (2014) 0.81
Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma. Glycoconj J (2015) 0.81
Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering. Appl Microbiol Biotechnol (2015) 0.80
Recent advances in cellular glycomic analyses. Biomolecules (2013) 0.80
Microscale separation of heparosan, heparan sulfate, and heparin. Anal Biochem (2012) 0.80
Compositional analysis and structural elucidation of glycosaminoglycans in chicken eggs. Glycoconj J (2014) 0.80
Capillary electrophoresis for total glycosaminoglycan analysis. Anal Bioanal Chem (2014) 0.80
Signal amplification by glyco-qPCR for ultrasensitive detection of carbohydrates: applications in glycobiology. Angew Chem Int Ed Engl (2012) 0.80
Bioengineering murine mastocytoma cells to produce anticoagulant heparin. Glycobiology (2013) 0.79
Heparan sulfate domains required for fibroblast growth factor 1 and 2 signaling through fibroblast growth factor receptor 1c. J Biol Chem (2016) 0.78
Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes. Glycoconj J (2013) 0.77
Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin. Biotechnol J (2015) 0.77
Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction. Anal Chem (2014) 0.77
Catch and Release DNA Decoys: Capture and Photochemical Dissociation of NF-κB Transcription Factors. ACS Chem Biol (2016) 0.76
Intact glycosaminoglycans from intervertebral disc-derived notochordal cell-conditioned media inhibit neurite growth while maintaining neuronal cell viability. Spine J (2015) 0.76
Analysis of heparin oligosaccharides by capillary electrophoresis-negative-ion electrospray ionization mass spectrometry. Anal Bioanal Chem (2016) 0.75
Identification of keratan sulfate disaccharide at C-3 position of glucuronate of chondroitin sulfate from Mactra chinensis. Biochem J (2016) 0.75
A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan. Biotechnol Prog (2015) 0.75
Surface modification of a polyethylene film for anticoagulant and anti-microbial catheter. React Funct Polym (2016) 0.75
Profiling pneumococcal type 3-derived oligosaccharides by high resolution liquid chromatography-tandem mass spectrometry. J Chromatogr A (2015) 0.75
Isolation and structural characterization of glycosaminoglycans from heads of red salmon (Oncorhynchus nerka). Jacobs J Biotechnol Bioeng (2014) 0.75
Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells. Cytotechnology (2014) 0.75
Determination of the unsaturated disaccharides of hyaluronic acid in equine synovial fluid by high-performance liquid chromatography and fluorescence detection. Acta Vet Scand (2015) 0.75
Purification and sequence characterization of chondroitin sulfate and dermatan sulfate from fishes. Glycoconj J (2017) 0.75
A modified uronic acid carbazole reaction. Anal Biochem (1962) 34.83
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Heparin-protein interactions. Angew Chem Int Ed Engl (2002) 7.27
Proteoglycans: structures and interactions. Annu Rev Biochem (1991) 6.53
The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol (2006) 2.36
Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol (2005) 2.28
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med (2011) 2.21
Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol (2000) 2.01
Synthesis and sorting of proteoglycans. J Cell Sci (2000) 1.96
Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol (2010) 1.93
Ultrahigh-pressure reversed-phase liquid chromatography in packed capillary columns. Anal Chem (1997) 1.73
Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J Biol Chem (2006) 1.55
Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology (1994) 1.38
Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal Biochem (2011) 1.28
Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column. Anal Biochem (2006) 1.27
A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology (2008) 1.23
Structural characterization of human liver heparan sulfate. Biochim Biophys Acta (2004) 1.18
Accelerated stability studies of heparin. J Pharm Sci (1996) 1.17
Determination of twelve heparin- and heparan sulfate-derived disaccharides as 2-aminoacridone derivatives by capillary zone electrophoresis using ultraviolet and laser-induced fluorescence detection. Electrophoresis (2002) 1.13
Ultraperformance liquid chromatography with electrospray ionization ion trap mass spectrometry for chondroitin disaccharide analysis. Anal Biochem (2009) 1.10
High-performance liquid chromatographic separation of heparin-derived oligosaccharides. Anal Biochem (1985) 1.09
Microanalysis of glycosaminoglycan-derived disaccharides labeled with the fluorophore 2-aminoacridone by capillary electrophoresis and high-performance liquid chromatography. Anal Biochem (1995) 1.09
Heparin characterization: challenges and solutions. Annu Rev Anal Chem (Palo Alto Calif) (2011) 1.09
Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli. Biochem Biophys Res Commun (1996) 1.08
High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides. Nat Protoc (2010) 1.07
Rapid purification and high sensitivity analysis of heparan sulfate from cells and tissues: toward glycomics profiling. J Biol Chem (2009) 1.06
Analysis of glycosaminoglycans with polysaccharide lyases. Curr Protoc Mol Biol (2001) 1.04
Cloning, sequencing, and expression of the gene from bacillus circulans that codes for a heparinase that degrades both heparin and heparan sulfate. Biosci Biotechnol Biochem (2002) 1.02
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations. Anal Biochem (2009) 1.02
Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin. Comp Biochem Physiol C Toxicol Pharmacol (2003) 1.01
High-performance liquid chromatography and on-line mass spectrometry detection for the analysis of chondroitin sulfates/hyaluronan disaccharides derivatized with 2-aminoacridone. Anal Biochem (2009) 1.01
Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests. Anal Chem (2010) 0.98
Improved workup for glycosaminoglycan disaccharide analysis using CE with LIF detection. Electrophoresis (2008) 0.97
Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J Chromatogr A (2008) 0.93
Randomness in the heparin polymer: computer simulations of alternative action patterns of heparin lyase. Biopolymers (1990) 0.92
Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin. Biochemistry (1999) 0.92
Biosynthesis and metabolism of sulfated glycosaminoglycans during Drosophila melanogaster development. Glycobiology (2004) 0.91
Analysis of glycosaminoglycans in stem cell glycomics. Methods Mol Biol (2011) 0.86
Insights into the capillary electrophoresis separation of heparin disaccharides from nuclear magnetic resonance, pKa, and electrophoretic mobility measurements. Anal Chem (2009) 0.86
Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate. Comp Biochem Physiol B Biochem Mol Biol (2005) 0.85
The biosynthesis of hyaluronic acid. Adv Carbohydr Chem (1957) 0.85
Glycosaminoglycans of the porcine central nervous system. Biochemistry (2010) 0.84
Retention mechanism for ion-pair chromatography with chaotropic reagents. J Chromatogr A (2008) 0.84
Rapid characterization and quality control of complex cell culture media solutions using raman spectroscopy and chemometrics. Biotechnol Bioeng (2010) 0.83
Extended thermodynamic approach to ion interaction chromatography. Anal Chem (2001) 0.81
Heparin-protein interactions. Angew Chem Int Ed Engl (2002) 7.27
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol (2007) 3.73
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem (2003) 2.94
Lessons learned from the contamination of heparin. Nat Prod Rep (2009) 2.81
Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science (2011) 2.79
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology (2005) 2.46
The proteoglycan bikunin has a defined sequence. Nat Chem Biol (2011) 2.14
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev (2005) 2.10
Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc (2008) 2.02
Flexible energy storage devices based on nanocomposite paper. Proc Natl Acad Sci U S A (2007) 2.02
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet (2004) 1.92
Electron detachment dissociation of glycosaminoglycan tetrasaccharides. J Am Soc Mass Spectrom (2006) 1.89
Enzymatic redesigning of biologically active heparan sulfate. J Biol Chem (2005) 1.89
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol (2006) 1.71
Heparin-binding domains in vascular biology. Arterioscler Thromb Vasc Biol (2004) 1.71
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Natl Acad Sci U S A (2004) 1.70
Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet (2003) 1.66
E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng (2010) 1.65
Chemoenzymatic design of heparan sulfate oligosaccharides. J Biol Chem (2010) 1.64
Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachment dissociation. Anal Chem (2007) 1.61
Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J Biol Chem (2002) 1.53
Liquid chromatography/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J Biol Chem (2003) 1.51
Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J Proteome Res (2007) 1.46
Ionic liquid-mediated selective extraction of lignin from wood leading to enhanced enzymatic cellulose hydrolysis. Biotechnol Bioeng (2009) 1.46
Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry. Anal Chem (2009) 1.45
Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J Biol Chem (2004) 1.42
Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J Biol Chem (2004) 1.41
Electron detachment dissociation of dermatan sulfate oligosaccharides. J Am Soc Mass Spectrom (2007) 1.40
Influence of charge state and sodium cationization on the electron detachment dissociation and infrared multiphoton dissociation of glycosaminoglycan oligosaccharides. J Am Soc Mass Spectrom (2008) 1.40
Negative electron transfer dissociation of glycosaminoglycans. Anal Chem (2010) 1.39
Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J Biol Chem (2004) 1.38
Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem (2008) 1.38
Structural analysis of bikunin glycosaminoglycan. J Am Chem Soc (2008) 1.37
Orthogonal analytical approaches to detect potential contaminants in heparin. Proc Natl Acad Sci U S A (2009) 1.36
Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Appl Microbiol Biotechnol (2011) 1.33
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry (2004) 1.33
Heparin accelerates gelsolin amyloidogenesis. Biochemistry (2006) 1.31
Room temperature ionic liquids as emerging solvents for the pretreatment of lignocellulosic biomass. Biotechnol Bioeng (2011) 1.31
Analysis of E. coli K5 capsular polysaccharide heparosan. Anal Bioanal Chem (2010) 1.30
Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions. Biochem Biophys Res Commun (2005) 1.29
Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal Biochem (2011) 1.28
Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column. Anal Biochem (2006) 1.27
Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. Anal Chem (2012) 1.26
Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides. Curr Med Chem (2003) 1.25
Proteoglycomics: recent progress and future challenges. OMICS (2010) 1.25
Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin. J Med Chem (2010) 1.24
Electron-induced dissociation of glycosaminoglycan tetrasaccharides. J Am Soc Mass Spectrom (2008) 1.23
The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery. J Biol Chem (2004) 1.23
Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta (2005) 1.22
Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry (2008) 1.21
Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively. Carbohydr Res (2002) 1.20
Preparation of biopolymer fibers by electrospinning from room temperature ionic liquids. Biomacromolecules (2006) 1.19
Engineering of routes to heparin and related polysaccharides. Appl Microbiol Biotechnol (2011) 1.19
Structural characterization of human liver heparan sulfate. Biochim Biophys Acta (2004) 1.18
Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE. J Pharm Sci (2009) 1.16
Isolation and characterization of heparan sulfate from various murine tissues. Glycoconj J (2006) 1.15
Immobilization of heparin: approaches and applications. Curr Top Med Chem (2008) 1.14
High-resolution crystal structure of Arthrobacter aurescens chondroitin AC lyase: an enzyme-substrate complex defines the catalytic mechanism. J Mol Biol (2004) 1.14
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Mol Cell Biol (2005) 1.13
Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities. Biomacromolecules (2009) 1.12
Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins. Biochem Pharmacol (2009) 1.12
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. Proc Natl Acad Sci U S A (2012) 1.11
Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. Am J Respir Cell Mol Biol (2009) 1.11
Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages. Glycobiology (2010) 1.11
Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J Med Chem (2008) 1.11
Ultraperformance liquid chromatography with electrospray ionization ion trap mass spectrometry for chondroitin disaccharide analysis. Anal Biochem (2009) 1.10
Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation. Anal Chem (2012) 1.10
Kinetic and structural studies on interactions between heparin or heparan sulfate and proteins of the hedgehog signaling pathway. Biochemistry (2007) 1.10
Recent progress and applications in glycosaminoglycan and heparin research. Curr Opin Chem Biol (2009) 1.10
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res (2011) 1.09
Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes. Biochemistry (2009) 1.09
Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab Eng (2012) 1.09
Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties. Nanotechnology (2009) 1.08
Structural characterization of pharmaceutical heparins prepared from different animal tissues. J Pharm Sci (2013) 1.08
Structural characterization of glycosaminoglycans from zebrafish in different ages. Glycoconj J (2008) 1.08
Structural characterization of heparins from different commercial sources. Anal Bioanal Chem (2011) 1.07
Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett (2007) 1.07
High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides. Nat Protoc (2010) 1.07
Separation of a complex mixture of heparin-derived oligosaccharides using reversed-phase high-performance liquid chromatography. J Chromatogr A (2003) 1.06
High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis. Anal Biochem (2010) 1.06
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05
Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site. Carbohydr Res (2002) 1.05
Mosquito heparan sulfate and its potential role in malaria infection and transmission. J Biol Chem (2007) 1.05
Toward an artificial Golgi: redesigning the biological activities of heparan sulfate on a digital microfluidic chip. J Am Chem Soc (2009) 1.04
Glycosaminoglycans in infectious disease. Biol Rev Camb Philos Soc (2013) 1.04
Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance. Malar J (2009) 1.03
Chemoenzymatic synthesis of heparan sulfate and heparin. Nat Prod Rep (2014) 1.03
Tandem MS can distinguish hyaluronic acid from N-acetylheparosan. J Am Soc Mass Spectrom (2007) 1.02
Matrix-assisted laser desorption/ionization mass spectrometric analysis of uncomplexed highly sulfated oligosaccharides using ionic liquid matrices. Anal Chem (2006) 1.02
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations. Anal Biochem (2009) 1.02
Blood compatible carbon nanotubes--nano-based neoproteoglycans. Langmuir (2006) 1.02
Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties. Curr Pharm Des (2003) 1.02
Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds. J Nutr Biochem (2009) 1.01
An 'omics approach towards CHO cell engineering. Biotechnol Bioeng (2013) 1.01
Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin. Comp Biochem Physiol C Toxicol Pharmacol (2003) 1.01
Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains. Glycobiology (2013) 1.00